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Sunhyo Ryu1,6, Soon-Yong Choi2,6, Samudra Acharya1, Young-Jin Chun3, Catherine Gurley1,
Yoonkyung Park4, Cheryl A. Armstrong1, Peter I. Song1 and Beom-Joon Kim5
The lipophilic fungus Malassezia furfur (M. furfur) is a commensal microbe associated with several chronic diseases
such as pityriasis versicolor, folliculitis, and seborrheic dermatitis. Because M. furfur-related diseases are difficult to
treat and require prolonged use of medications, the treatment for M. furfur-related skin diseases is supposed to gain
control over M. furfur growth and the inflammation associated with it, as well as to prevent secondary infections.
In this study, we investigated the antifungal and anti-inflammatory effects of cecropin A(1-8)–magainin 2(1-12)
hybrid peptide analog P5 on M. furfur. The minimal inhibitory concentration of P5 against M. furfur was 0.39mM,
making it 3–4 times more potent than commonly used antifungal agents such as ketoconazole (1.5mM) or
itraconazole (1.14mM). P5 efficiently inhibited the expression of IL-8 and Toll-like receptor 2 in M. furfur-infected
human keratinocytes without eukaryotic cytotoxicity at its fungicidal concentration. Moreover, P5 significantly
downregulated NF-kB activation and intracellular calcium fluctuation, which are closely related with enhanced
responses of keratinocyte inflammation induced by M. furfur infection. Taken together, these observations
suggest P5 may be a potential therapeutic agent for M. furfur-associated human skin diseases because of its
distinct antifungal and anti-inflammatory action.
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INTRODUCTION
The skin and gastrointestinal tract are colonized by over 500
commensal microbial species that are estimated to make up
over 95% of the cells present in the human body (Round
et al., 2010). Like other skin commensals, the non-pathogenic
yeast Malassezia furfur (M. furfur) can undergo transition to a
pathogenic form under favorable conditions (Gaitanis et al.,
2009). At high concentrations, this opportunistic organism
diminishes the normal protective barrier of skin and affects
the body’s ability to control inflammation. In fact, M. furfur is
associated with pityriasis versicolor (Keddie, 1966), follicu-
litis (Back et al., 1985), seborrheic dermatitis (Bergbrant
and Faergemann, 1990), some forms of atopic dermatitis
(Waersted and Hjorth, 1985),and psoriasis (Rosenberg and
Noah, 1988). These M. furfur-related diseases are often
difficult to treat and require prolonged use of antifungal and
anti-inflammatory medications. As such, the goals of treat-
ment for many of these skin diseases are to gain control over
M. furfur’s growth and associated inflammation, and to
prevent the occurrence of secondary infections (Gupta et al.,
2004; Gaitanis et al., 2009). However, recently available
antifungal drugs to treat this fungal infection are highly toxic
and costly when used in prolonged treatments (Liss and
Batchelor, 1987).
As both mammalian and fungal cells are eukaryotic,
finding an effective antifungal that is non-cytotoxic to
mammalian cells remains a challenge. A promising approach
for developing new cutaneous antifungals may lie with
antimicrobial peptides (AMPs) because of their ability to
efficiently kill microbial pathogens. AMPs can be classified as
either cytotoxic or non-cytotoxic. Cytotoxic AMPs such as
melittin can lyse mammalian cells as well as bacterial cells
(Habermann and Jentsch, 1967), whereas non-cytotoxic
AMPs such as cecropin A (CA; a cationic 37-amino acid;
Steiner et al., 1981; van Hofsten et al., 1985; Lee et al., 1989)
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and magainin 2 (MA; a cationic 23-amino acid; Zasloff,
1987) affect only bacteria. Recent studies suggest that the
principal action mode of these amphipathic AMPs involves
the formation of ion channels, with subsequent disruption of
bacterial phospholipid bilayers and eventual cell death
(Huang, 2000; Kim et al., 2001; Lee et al., 2002; Saint
et al., 2002). Structural modifications of natural AMPs may be
a promising strategy for developing a new class of drugs to
more efficiently prevent and treat M. furfur-related skin
diseases.
Recently, our group has focused on the design of synthetic
AMP analogs that exhibit potent antimicrobial activity and
low cytotoxicity to eukaryotic cells (Park et al., 2003; Gopal
et al., 2009). These modifications increased the net positive
charge and hydrophobicity of the helix region, giving these
AMPs enhanced antimicrobial activity. In this study, we
examined the antifungal and anti-inflammatory properties
using one of the modified synthetic AMP P5 (Park et al.,
2003), which is a synthetic CA–MA hybrid peptide analog,
against M. furfur in normal human keratinocytes.
RESULTS AND DISCUSSION
Minimal inhibitory concentration (MIC) of P5 against M. furfur
was significantly lower than the known antifungal agents and its
negative control peptide P4
To determine fungicidal activities of the newly designed
AMPs, we tested the MIC of P5 and its negative control
peptide P4 against M. furfur ATCC43132 (ATCC, Manassas,
VA) by the microdilution method. The MIC values of peptides
P5 and P4 were 0.39 and higher than 3.125mM, respectively
(Table 1, Supplementary Figure S1 online). The MIC value of
P5 against M. furfur was 3–4 times lower than known
antifungal agents such as ketoconazole (1.5 mM) or itracona-
zole (1.14 mM) (Strippoli et al., 1997), and 8 times lower than
its negative control peptide P4.
P5 non-cytotoxic effect on human keratinocytes
To determine the cytotoxic effects of the structurally modified
AMPs on normal human keratinocytes, we measured HK cell
viability by MTT (yellow tetrazolium salt; 3-(4,5-dimethylthi-
azol-2-yl)-2,5-diphenyltetrazolium bromide) assay 24hours
after treatment with various concentrations of P5 or negative
control peptide P4. The percentages of HK cell viability after
treatment with 1.6, 3.2, and 6.4 mM of P5 or P4 were 100,
496, and 460%, respectively (Table 2). In contrast,
treatment with 2% Triton X-100 resulted in less than 2%
HK cell viability. These results demonstrate that P5 and P4
do not have any significant cytotoxic effect on cultured HK at
their physiologically effective antifungal concentration.
Inhibitory effect of P5 on the expression of IL-8 induced by
M. furfur infection in normal human keratinocytes
IL-8 is a strong chemotactic factor for neutrophils and
lymphocytes, which sustain the defense of the skin against
pathogens by attracting inflammatory cells to the infection
sites (Mukaida, 2000). We examined the effect of AMPs on
the M. furfur-induced HK IL-8 mRNA expression by real-time
RT-PCR. HK cells were treated for 8–24 hours with M. furfur
at a yeast cell to HK ratio of 27:1 in the presence or absence
of 0.8 mM P5 or P4. The IL-8 mRNA expression was increased
in M. furfur-treated keratinocytes, which concurs with
previously published data (Baroni et al., 2006). This increase
reached a maximum at 8 hours with M. furfur infection.
However, when keratinocytes were treated with M. furfur
plus P5, the P5 significantly downregulated the M. furfur-
induced IL-8 mRNA expression (Figure 1a, Supplementary
Figure S2 online). In contrast, the expression was not
inhibited by the treatment with M. furfur plus negative
control peptide P4. We next determined P5 effects on the
secretion of HK IL-8 proteins induced by M. furfur infection.
P5 significantly inhibited (more than 15%) M. furfur-induced
IL-8 protein secretion compared with the inhibition rate by P4
(0%) 24 hours after the treatment (Figure 1b). There was no
increased secretion of IL-8 proteins induced by the treatment
with P5 and P4 peptides alone.
P5 blocks NF-jB nuclear translocation induced by M. furfur
infection in normal human keratinocytes
In unstimulated human keratinocytes, NF-kB is detected in
the cytoplasm in association with IkB. In response to cell
stimulation, IkB kinases are rapidly activated, resulting in
phosphorylated IkB, which is then degraded by the 26S
proteasome. Once NF-kB is separated from IkB, it translo-
cates to the nucleus to activate transcription of a variety of
proinflammatory genes (Karin, 1999).
To test the role of P5 in mediating NF-kB responses to
M. furfur infection, we analyzed NF-kB nuclear translocation.
Non-treated keratinocytes demonstrated primarily cytoplas-
mic NF-kB staining (Figure 2a), whereas, M. furfur infection
induced a rapid NF-kB nuclear translocation (Figure 2b).
However, the coincubation with M. furfur plus P5 mostly
abrogated the M. furfur-induced NF-kB nuclear translocation
(Figure 2c). In contrast, when keratinocytes were incubated
with M. furfur plus negative control peptide P4, no inhibition
Table 1. The MIC values of synthetic AMPs P5 and P4
against M. furfur
AMP
MIC (lM) against
M. furfur
P5 (KWKKLLKKPLLKKLLKKL-NH2) o0.39
P4 (inactive control: KWKKKKKKPKFL-NH2) 43.125
Abbreviations: AMP, antimicrobial peptide; M. furfur, Malassezia furfur;
MIC, minimal inhibitory concentration.
Table 2. HK cell viability in the presence of AMPs
Concentration (lM) P5 P4
Triton
X-100
1.6 100% 100% o2%
3.2 496% 496% —
6.4 460% 460% —
Abbreviation: AMP, antimicrobial peptide.
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of NF-kB nuclear translocation was observed (Figure 2d).
These results indicate that P5 is capable of blocking the HK
NF-kB nuclear translocation induced by M. furfur infection.
Rapid intracellular calcium fluctuation induced by M. furfur
infection was abrogated by P5 in normal human keratinocytes
We next examined the functional competence of P5 to
respond to M. furfur infection. HK cells were treated with
M. furfur at a yeast cell to HK ratio of 27:1 in the presence or
absence of 0.8 mM P5 or P4. M. furfur-infected keratinocytes
resulted in a rapid intracellular Ca2þ fluctuation (Figure 3a).
Each peak in this figure represents the rapid response of
individual keratinocytes to M. furfur. When keratinocytes
were preincubated with 0.8 mM P5 for 2 hours before the
addition of M. furfur, the rapid intracellular Ca2þ fluctuation
was efficiently abrogated (Figure 3b). In contrast, when
keratinocytes were preincubated with 0.8 mM P4, no inhibi-
tion of intracellular calcium fluctuation was observed at the
M. furfur treatment (Figure 3b). Stimulation with peptides
alone showed little changes in intracellular Ca2þ fluctuation
(Figure 3c and d). These results demonstrate that P5 inhibits
the rapid response of keratinocyte intracellular calcium follow-
ingM. furfur infection, thus indicating its functional competence.
Inhibitory effect of P5 on the expression of HK TLR2 induced by
M. furfur infection
As Baroni et al. (2006) reported that M. furfur induced IL-8
expression via Toll-like receptor 2 (TLR2) signal-transduction
pathway in human keratinocytes obtained from surgical
specimens of normal adult skin, we next examined P5 effect
on the M. furfur-induced HK TLR2 mRNA expression by real-
time RT-PCR. HK cells were treated with M. furfur at a yeast
cell to HK ratio of 27:1 in the presence or absence of 0.8 mM
P5 or P4. The TLR2 mRNA expression was 1.5-fold more
increased in M. furfur-treated keratinocytes 8 hours after the
treatment. In contrast, when keratinocytes were treated with
M. furfur plus P5, the increased TLR2 mRNA expression was
significantly downregulated by P5 (Po0.0002), but not by
P4 (Figure 4a). Moreover, P5 mostly inhibited M. furfur-
induced cellular expression of TLR2 proteins compared with
negative control peptide P4 24 hours after the treatment
(Figure 4b). These results demonstrate that P5 efficiently
inhibits the M. furfur-induced TLR2 expression in normal
human keratinocytes.
Ketoconazole, a synthetic lipophilic antifungal imidazolic
drug, is mainly prescribed for skin fungal infections (Urcuyo
and Zaias, 1982; Ford et al., 1984; Savin, 1984; Gupta et al.,
2004), and is very effective in vitro against Malassezia
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Figure 2. Malassezia furfur (M. furfur)-induced NF-jB nuclear translocation
was inhibited by P5 in normal human keratinocytes. Immunolocalization
of NF-kB was determined by immunofluorescent staining of cellular NF-kB
using chamber slide-cultured normal human keratinocytes, which were
infected by M. furfur (27:1) for 30minutes in the presence or absence of
0.8mM P5 or P4. NF-kB was detected by specific anti-NF-kB p65 polyclonal
antibodies (anti-NF-kB pAbs). FITC-labeled NF-kB (green) was shown with
Hoechst-stained nucleus (blue). Images were acquired with the QICAM fast
1394 camera (McCrone Microscopes & Accessories, Westmont, IL). (a) Non-
treated; (b) treated with M. furfur; (c) treated with M. furfur plus P5; and
(d) treated with M. furfur plus P4. Bars¼ 20 mm.
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Figure 1. Cecropin A–magainin 2 (CA–MA) hybrid peptide analog P5
inhibits the expression of IL-8 induced by Malassezia furfur (M. furfur)
infection in normal human keratinocytes. (a) Total RNA was obtained from
cultured normal human keratinocytes, which were infected by M. furfur (27:1)
for 8hours in the presence or absence of 0.8mM P5 or P4. The expression of
IL-8 mRNA was measured by real-time RT-PCR using human IL-8-specific sense
and antisense primers, as described in ‘‘Materials and Methods’’. The relative
intensity of each mRNA expression was normalized with mRNA expression of
18S rRNA. (b) The secretion of IL-8 induced by the M. furfur infection was
measured by ELISA, as described in ‘‘Materials and Methods’’. Cultured HK cell
supernatants were collected 24hours after infection with M. furfur (27:1) in the
presence or absence of 0.8mM P5 or P4. HK treatment with 0.8mM P5 or P4
alone served as controls. The data shown are representative of triplicate
experiments. All values are expressed as mean±SD. Statistically significant
differences in the expression of IL-8 mRNA and the secretion of IL-8 were
determined by analysis of variance with probabilities shown for both the
overall significance and the pairwise comparison (*Po0.001).
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species (Faergemann, 2000). However, when administered
orally, ketoconazole accumulates in fatty tissues, leading to
important side effects, such as severe toxic hepatitis and
acquired cutaneous adherence (Svedhem, 1984; Knight et al.,
1991; Polsen et al., 1995). Therefore, it is necessary to find
new compounds to treat Malassezia infections.
AMPs are an emerging concept as an innate defense
mechanism of the epithelial barrier. For example, cathelici-
dins and other cationic AMPs are active against M. furfur,
Trichophyton mentagrophytes, and T. rubrum, which typi-
cally colonize superficially on the skin (Lopez-Garcia et al.,
2006). Two forms of cathelicidin peptides, which were found
in human neutrophils (LL-37) and mouse granulocytes
(CRAMP), inhibited the growth of M. furfur with MIC values
of 20–30 mM (Scott and Hancock, 2000; Lopez-Garcia et al.,
2006). We also reported a powerful exogenous antifungal
CA–MA hybrid peptide P5, which was specifically designed
by substitution of certain amino acids in the flexible region
of CA–MA as well as altering some Lys and Leu positions in
the CA–MA peptide (Park et al., 2003). P5 showed a 2-fold
greater antifungal activity against Candida albicans than
CA–MA without mammalian cell cytotoxicity (Park et al.,
2003). In this study, we demonstrate for the first time the
highly potent inhibitory effects of P5 on M. furfur infection in
human keratinocytes. The in vitro antifungal activity of
previously known antifungal agents such as ketoconazole
or itraconazole required a dosage 3–4 times higher (more
than 1.14 mM; Strippoli et al., 1997) than that of P5 (less than
0.39 mM, Table 1). Therefore, P5 may have significant
potential as a pharmacological agent to protect the skin
against M. furfur infection.
Malassezia yeast such as M. furfur is not only a human
cutaneous commensal but also a causative organism of
superficial dermatoses. Its first point of contact with the
immune system is likely to be via the skin immune system.
It has been demonstrated that M. furfur activates monocytes
and polymorphonuclear leukocytes, which in turn produce
proinflammatory cytokines such as IL-8 (Suzuki et al., 2000).
However, the mechanism of M. furfur on the production of
proinflammatory cytokines in normal human keratinocytes
has not been well studied. When we examined the effect of
P5 on the HK cytokine production induced by M. furfur
infection, the expression of IL-8 was significantly reduced by
P5 treatment (Figure 1). Recent studies suggest that the
microbial components use TLRs to transduce their signals
because TLRs are capable of initiating innate immune
responses and influencing subsequent adaptive immune
responses in various cells (Netea et al., 2002; Pivarcsi
et al., 2003). In particular, Baroni et al. (2006) reported that
M. furfur induced IL-8 expression via TLR2 signal-transduc-
tion pathway in human keratinocytes obtained from surgical
specimens of normal adult skin. Furthermore, TLR2 activation
leads to promoting expression of genes of proinflammatory
cytokines via NF-kB transcriptional factor (Takeda and Akira,
2004). As demonstrated in Figures 2 and 4, M. furfur-induced
TLR2 expression was significantly reduced by P5 treatment in
normal human keratinocytes. Moreover, P5 efficiently
inhibited M. furfur-induced NF-kB nuclear translocation.
Our results indicate that P5 negatively regulates the activa-
tion of TLR2 through NF-kB inactivation in M. furfur-infected
human keratinocytes.
Ca2þ signaling implicated in various steps of microbial
infection is also activated via TLR signaling (Chun and Prince,
2006; Zhou et al., 2006). Forslind et al., (1999) have reported
an abnormal distribution of intracellular calcium in the skin
from patients with atopic dermatitis or psoriasis triggered by
the lipophilic yeast M. furfur. M. furfur contains lipases,
which hydrolyze triglycerides to free specific saturated fatty
acids required for yeast proliferation.M. furfur-generated free
fatty acids can elicit a flaking response in dandruff-
susceptible individuals (Ro and Dawson, 2005). Unsaturated
fatty acids in sebum of the hair canal and on the skin surface
alter the calcium dynamics in epidermal keratinocytes and
induce abnormal follicular keratinization (Katsuta et al.,
2005). An influx of calcium into epidermal keratinocytes
delays recovery of the skin barrier function, resulting in
inducing epidermal hyperplasia (Denda et al., 2002;
Fuziwara et al., 2003). These results suggest that the free
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Figure 3. P5 inhibited Malassezia furfur (M. furfur)-induced intracellular calcium fluctuation in normal human keratinocytes. Normal human keratinocytes
were grown on glass coverslip culture dishes to approximately 50–70% confluency. Then 2 mM fluorescent calcium probe fura-2/acetylmethyl was
incorporated. Intracellular calcium fluctuation was determined, as described in ‘‘Materials and Methods’’. (a) HK cells were treated with M. furfur at a
yeast cell to HK ratio of 27:1. (b) HK cells were preincubated with 0.8 mM P5 or P4 for 2 hours, then treated with M. furfur (27:1). (c, d) HK cells were treated
with 0.8mM P5 (c) and P4 (d) alone. Intracellular free calcium concentration (nM) was determined by measuring the ratio of fluorescence at excitation
wavelengths of 340 and 380 nm. Each peak in the figure represents the rapid intracellular calcium response of individual cell. Arrows are the points of treatment
with M. furfur (a, b), P5 (c), and P4 (d), respectively.
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fatty acids in sebum alter the calcium dynamics in epidermal
keratinocytes and induce abnormal skin destruction. In this
study, we demonstrated for the first time that P5 significantly
inhibited M. furfur-induced intracellular calcium fluctuation
in normal human keratinocytes (Figure 3), indicating P5 as a
new class of negative regulator of the calcium fluctuation.
Taken together, because of a dual mechanism of
antifungal and anti-inflammatory action distinct from com-
monly used antifungal agents, P5 may be a significant
potential as a therapeutic agent for M. furfur-associated
human skin diseases.
MATERIALS AND METHODS
Reagents and cells
M. furfur (ATCC43132) was cultured on agar plates of Sabouraud
dextrose medium (BD, Franklin Lakes, NJ) containing 0.1% glycerol,
0.5% Tween 80, and 0.8% olive oil for 3–4 days at 32 1C. Normal
human keratinocytes from foreskin were purchased from PromoCell
(Heidelberg, Germany) and cultured in supplemented keratinocyte
growth medium at 37 1C with 5% CO2. HK cells were subsequently
maintained under subconfluent conditions. Starvation medium was
prepared using supplemented growth medium without hydrocorti-
sone and bovine pituitary extract.
Synthetic CA–MA hybrid peptides P5 and P4
A synthetic CA–MA hybrid peptide P5 (KWKKLLKKPLLKKLLKKL-
NH2) was specifically designed by substitution of certain amino
acids in the flexible region of CA–MA as well as altering some
Lys and Leu positions in the CA–MA peptide (Park et al., 2003).
P4 (KWKKKKKKPKFL-NH2) served as a negative control AMP of P5,
as it exhibits little antimicrobial activity.
Treatment of HK with M. furfur in the presence or absence of
AMPs
Cultured HK cells with 70% confluency in six-well plates were
infected with M. furfur at a yeast cell to HK ratio of 27:1, then
subsequently incubated for the indicated time periods. A 27:1 cell
ratio allows for optimal cytokine stimulation, as demonstrated in
our preliminary experiments and the previously published informa-
tion (Suzuki et al., 2000; Baroni et al., 2006). Following infection
withM. furfur, 0.8 mM P5, P4, or starvation media alone was added to
each well. Non-treated HK cells served as a negative control.
Cultured cell supernatants from each time point were collected and
centrifuged at 14,000 g at 4 1C for 10minutes to obtain the cell-
free samples.
MIC test by microdilution assays
M. furfur was cultured at 32 1C on Sabouraud dextrose agar plates
containing glycerol monostearate plus olive oil. Several colonies of
M. furfur were collected from the agar plates and suspended in
Sabouraud dextrose liquid media to a concentration of 4 106
colony-forming units per ml. Two-fold serial dilutions of the peptide
(0.39–100mM) were prepared in the liquid media and plated into
sterile 96-well microtiter plates. The suspension of M. furfur was
then added to each well, and the microtiter plates were incubated
overnight at 32 1C. TheM. furfur plus AMP suspension was collected
from the wells and aliquoted. Individual aliquots were then plated
onto Sabouraud dextrose agar plates and incubated at 32 1C for
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Figure 4. P5 inhibits the expression of Toll-like receptor 2 (TLR2) induced
by Malassezia furfur (M. furfur) infection in normal human keratinocytes.
(a) Total RNA was obtained from cultured normal human keratinocytes,
which were infected byM. furfur (27:1) for 8 hours in the presence or absence
of 0.8 mM P5 or P4. The expression of TLR2 mRNA was measured by real-time
RT-PCR using human TLR2-specific sense and antisense primers, as described
in ‘‘Materials and Methods’’. The relative intensity of each mRNA expression
was normalized with mRNA expression of 18S rRNA. The data shown are
representative of triplicate experiments. All values are expressed as
mean±SD. Statistically significant differences in the expression of TLR2
mRNA were determined by analysis of variance, with probabilities shown
for both the overall significance and the pairwise comparison (*Po0.001).
(b) Chamber slide-cultured normal human keratinocytes were infected
by M. furfur (27:1) for 24 hours in the presence or absence of 0.8 mM P5
or P4. Immunolocalization of TLR2 was determined by immunofluorescent
staining using specific anti-TLR2 polyclonal antibodies, as described in
‘‘Materials and Methods’’. FITC-labeled TLR2 (green) was shown with
Hoechst-stained nucleus (blue). (i) Non-treated; (ii) treated with M. furfur;
(iii) treated with M. furfur plus P5; and (iv) treated with M. furfur plus P4.
Bars¼ 20 mm.
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3–4 days. Colony counts were obtained at the end of the incubation
period. The MIC was defined as the lowest concentration of peptide
that gave no visible growth on agar plates (Andrews, 2001).
MTT assay
A standard colorimetric assay for measuring the activity of MTT-
reducing enzymes was performed according to manufacturer’s
instruction. In brief, HK cells (5 103 per 200ml culture media)
were incubated at 37 1C for 24 hours in the presence or absence
of P5 or P4 concentrations ranging from 1.6 to 6.4mM. Then, 200 ml
of MTT (5mgml1) reagent was added to each well, and the cells
were incubated at 37 1C for 4 hours. Solubilization solution
(10% SDS in 0.01M HCl) was then added to the well, and the
absorbance was measured at 570 nm. The data are expressed as the
percentage of viable cells in comparison with that of 2% Triton
X-100-treated control.
Determination of IL-8 and TLR2 mRNA expression by real-time
RT-PCR
Total RNAs were isolated using a Rneasy Mini Kit (Qiagen,
Maryland, MD), then reverse transcribed to complementary DNA
for 2 hours at 42 1C using M-MLV reverse transcription kit (Promega,
Madison, WI) according to the manufacturer0s instructions. The
mRNA expression of target genes was analyzed by real-time RT-PCR,
as described in the manufacturer’s protocol (ABI 7500 real-time PCR
system using SYBR Green master mix; Applied Biosystems, Foster
City, CA). Oligonucleotide primers used to amplify human IL-8 and
TLR2 complementary DNA were designed by the manufacturer’s
software (Primer Express 3.0; Applied Biosystems) based on the
published sequences (Baggiolini and Clark-Lewis, 1992; Rock et al.,
1998; Snoussi et al., 2010). Target gene expression was normalized
using an internal control gene 18S rRNA (Torczynski et al., 1985).
The IL-8 primer sequences used were 50-GCAGTTTTGCCAAG
GAGTGCT-30 for the sense primer and 50-TTTCTGTGTTGGC
GCAGTGTG-30 for the antisense primer. The TLR2 primer sequences
used were 50-TGTCTTGTGACCGCAATGGT-30 for the sense
primer and 50-TGTTGGACAGGTCAAGGCTTT-30 for the antisense
primer. The 18S rRNA primer sequences used were 50-CGGCTA
CATCCAAGGAA-30 for the sense primer and 50-GCTGGAATTACCG
CGGCT-30 for the antisense primer.
Determination of IL-8 proteins secreted by M. furfur-infected
HK cells in the presence or absence of P5 by ELISA
To measure secreted IL-8 proteins, the collected supernatants were
tested by ELISA using Quantikine human IL-8 immunoassay kit
(R&D Systems, Minneapolis, MN) according to the manufacturer’s
instruction. In brief, 100 ml of assay diluent and 50 ml of the standards
or sample supernatants was added to 96-well plates, and then
incubated for 2 hours at room temperature. After washing for four
times, 100 ml of anti-human IL-8 antibody (1:200) was added to each
well, then incubated for 1 hour at room temperature. The absorbed
color intensities were measured by an ELISA reader at 450 nm.
All experiments were performed in triplicates.
Determination of NF-jB nuclear translocation by
immunofluorescence staining
Human keratinocytes grown to about 70% confluency into chamber
slides (154526, Nalgene Nunc, Rochester, NY) were treated with
M. furfur at a yeast cell to HK ratio of 27:1 for 1 hour in the presence
or absence of 0.8mM P5 or P4. After fixation with 4% formaldehyde
for 20minutes at room temperature, cells were incubated overnight
at 4 1C with rabbit anti-human NF-kB p65 polyclonal antibodies
(Rel A; Rockland, Gilbertsville, PA) diluted 1:3000 in blocking buffer
(ImmPRESS kit; Vector Laboratories, Burlingame, CA) with 0.1%
TritonX-100, which was added for permeabilization. Cells were then
incubated with secondary anti-rabbit Ig HRP antibody for 1 hour.
After washing, cells were incubated with TSA fluorescein reagent
(Perkin Elmer, Boston, MA) for 30minutes, and then incubated with
1mgml1 Hoechst 33342 (Invitrogen, Carlsbad, CA) for 30minutes
at room temperature. Dehydrated chamber slides were mounted and
visualized with a microscope (Olympus EX51; Center Valley, PA).
Determination of TLR2 cellular localization by
immunofluorescence staining
Cultured HK cells with 70% confluency in chamber slides were
treated with M. furfur at a yeast cell to HK ratio of 27:1 for 24 hours
in the presence or absence of 0.8 mM P5 or P4. HK cells were
incubated overnight at 4 1C with rabbit anti-human TLR2 antibodies
(Rockland) diluted 1:3,000.
Analysis of HK intracellular calcium mobilization
Intracellular calcium fluctuation was determined by InCyt Basic IM
Fluorescence Imaging System (Intracellular Imaging, Cincinnati,
OH) according to the manufacturer’s instruction. In brief, HK cells
were grown on glass coverslips to approximately 50–70% con-
fluency. Cells then were washed twice with phosphate-buffered
saline without Ca2þ and Mg2þ , then incubated for 45minutes at
37 1C in phosphate-buffered saline containing 2mM of the fluorescent
calcium probe fura-2/acetylmethyl ester (Invitrogen). After three
washes, cells were treated withM. furfur at a yeast cell to HK ratio of
27:1 in the presence or absence of 0.8mM P5 or P4 during analyses of
their fluorescence fluctuation.
Statistical analysis
For statistical analysis, analysis of variance with probabilities was
performed for both the overall significance (P) and the pairwise
comparison, indicated by asterisks. Po0.05 was considered to be
significant. Statistical analysis results are expressed as mean±SD.
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